Biopharma
Page 1 • 4 itemsGlobal biopharma insights for investors & BD. Track drug development, M&A, and market trends shaping the pharmaceutical landscape.
CHMP Positive Opinion Immunotherapy: Expanded Use in Advanced Lung Cancer
The CHMP's positive opinion on [Drug Name] marks a significant step towards expanded immunotherapy options for patients with advanced lung cancer.
EMA Conditional Approval CAR-T Therapy for Relapsed B-Cell Lymphoma
The EMA has granted conditional approval for CAR-T therapy, offering new hope for patients with relapsed B-cell lymphoma.
CHMP Positive Opinion CAR-T Therapy: What You Need to Know
The CHMP has issued a positive opinion for CAR-T therapy, a groundbreaking treatment for specific blood cancers, offering new hope for patients.
EU Pharmaceutical Legislation Reform: Impact on Biopharma Innovation
The EU Pharmaceutical Legislation Reform aims to enhance biopharma innovation, influencing drug development processes for critical therapies like Xyrem.